• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » First patient in Japan treated with Abiomed’s Impella 5.5 with SmartAssist

First patient in Japan treated with Abiomed’s Impella 5.5 with SmartAssist

April 6, 2022 By Sean Whooley

Abiomed Impella 5.5 with SmartAssist heart pump
This illustration shows the Impella 5.5 with SmartAssist placed in the heart. [Image courtesy of Abiomed]
Abiomed (Nasdaq:ABMD) announced today that the first patient in Japan was successfully treated with its Impella 5.5 with SmartAssist.

The first Impella 5.5 with SmartAssist procedure in Japan took place at Osaka Police Hospital. The treated patient was an 82-year-old man treated for cardiogenic shock.

“Our facility is proud to be the first in Japan to treat patients using Impella 5.5 with SmartAssist,” Osaka Police Hospital Director Dr. Yoshiki Sawa said in a news release. “We are excited to utilize this innovative technology and look forward to providing a minimally invasive surgical option for our acute heart failure patients.”

Additionally, the total number of patients around the globe that have been treated with Danvers, Massachusetts-based Abiomed’s Impella 5.5 with SmartAssist has now surpassed 5,000.

Dr. Tamer Attia of Emory University Hospital (Atlanta) performed the 5,000th procedure on a 41-year-old woman with cardiomyopathy.

“Impella 5.5 with SmartAssist has completely changed how we are able to support our cardiogenic shock and cardiomyopathy patients,” Emory University Hospital Chief of Thoracic Transplant and Mechanical Circulatory Support Surgery Dr. Mani Daneshmand said. “Given the safety and efficacy of Impella 5.5 with SmartAssist, Dr. Attia and his team are able to treat patients who otherwise would not have had other options for heart recovery.”

Abiomed designed the Impella 5.5 with SmartAssist as a minimally invasive platform that eliminates the need for a sternotomy or coring of the left ventricle while delivering forward flow to provide the patient with coronary flow and renal perfusion.

The system is fully unloading to reduce the heart’s oxygen demand and work, while SmartAssist provides weaning algorithms to optimize survival and native heart recovery.

Filed Under: Cardiac Implants, Cardiovascular, Featured, Structural Heart Tagged With: Abiomed

More recent news

  • Ambu wins FDA clearance for first single-use cysto-nephroscope
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy